Concepts (145)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Seminoma | 4 | 2016 | 137 | 1.120 |
Why?
|
Testicular Neoplasms | 4 | 2016 | 804 | 0.780 |
Why?
|
Prostatic Neoplasms | 16 | 2021 | 11124 | 0.660 |
Why?
|
Pelvic Neoplasms | 1 | 2020 | 254 | 0.650 |
Why?
|
Brachytherapy | 3 | 2021 | 1248 | 0.570 |
Why?
|
Radiosurgery | 2 | 2022 | 1329 | 0.500 |
Why?
|
Orchiectomy | 2 | 2016 | 474 | 0.490 |
Why?
|
Radiotherapy, Adjuvant | 3 | 2016 | 1770 | 0.420 |
Why?
|
Chemotherapy, Adjuvant | 3 | 2016 | 3479 | 0.330 |
Why?
|
Radiotherapy Dosage | 6 | 2021 | 2879 | 0.300 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2016 | 9239 | 0.290 |
Why?
|
Radiotherapy, Intensity-Modulated | 3 | 2021 | 806 | 0.260 |
Why?
|
Adenocarcinoma | 2 | 2021 | 6364 | 0.260 |
Why?
|
Quality of Life | 4 | 2021 | 12804 | 0.240 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 4 | 2013 | 1624 | 0.230 |
Why?
|
Urination Disorders | 2 | 2021 | 241 | 0.200 |
Why?
|
Radiation Injuries | 2 | 2021 | 1180 | 0.170 |
Why?
|
Watchful Waiting | 2 | 2015 | 492 | 0.170 |
Why?
|
Sexual Dysfunction, Physiological | 2 | 2021 | 360 | 0.170 |
Why?
|
Carcinoma, Renal Cell | 1 | 2014 | 3143 | 0.160 |
Why?
|
Cystectomy | 3 | 2013 | 686 | 0.160 |
Why?
|
Kidney Neoplasms | 1 | 2014 | 4262 | 0.150 |
Why?
|
Urinary Bladder Neoplasms | 3 | 2013 | 2245 | 0.130 |
Why?
|
Cancer Care Facilities | 2 | 2014 | 402 | 0.120 |
Why?
|
Neoplasm Staging | 7 | 2021 | 11031 | 0.120 |
Why?
|
Hospitals, Community | 1 | 2016 | 348 | 0.120 |
Why?
|
Male | 26 | 2021 | 350118 | 0.110 |
Why?
|
Rectum | 2 | 2021 | 904 | 0.110 |
Why?
|
Medical Oncology | 2 | 2014 | 2265 | 0.100 |
Why?
|
Proportional Hazards Models | 3 | 2016 | 12354 | 0.100 |
Why?
|
Androgen Antagonists | 1 | 2020 | 1377 | 0.100 |
Why?
|
Hospitals, Teaching | 1 | 2016 | 1179 | 0.100 |
Why?
|
Nomograms | 1 | 2013 | 228 | 0.100 |
Why?
|
Disease-Free Survival | 4 | 2015 | 6895 | 0.100 |
Why?
|
Middle Aged | 17 | 2021 | 213383 | 0.100 |
Why?
|
Kaplan-Meier Estimate | 3 | 2016 | 6538 | 0.090 |
Why?
|
Consumer Health Information | 1 | 2012 | 211 | 0.090 |
Why?
|
Aged | 15 | 2021 | 163280 | 0.090 |
Why?
|
Patient Care Management | 1 | 2013 | 306 | 0.090 |
Why?
|
Urinary Bladder | 2 | 2013 | 1172 | 0.090 |
Why?
|
Urologic Surgical Procedures | 1 | 2011 | 302 | 0.080 |
Why?
|
Aged, 80 and over | 5 | 2021 | 57776 | 0.080 |
Why?
|
Referral and Consultation | 4 | 2014 | 3528 | 0.080 |
Why?
|
Odds Ratio | 3 | 2016 | 9849 | 0.080 |
Why?
|
Epidemics | 1 | 2014 | 523 | 0.080 |
Why?
|
Combined Modality Therapy | 3 | 2017 | 8642 | 0.080 |
Why?
|
Photons | 1 | 2012 | 588 | 0.080 |
Why?
|
Nephrectomy | 1 | 2014 | 1050 | 0.080 |
Why?
|
Radiotherapy, Conformal | 1 | 2011 | 548 | 0.080 |
Why?
|
Hospitals, General | 1 | 2011 | 749 | 0.070 |
Why?
|
Humans | 27 | 2022 | 744343 | 0.070 |
Why?
|
Multivariate Analysis | 3 | 2016 | 12245 | 0.070 |
Why?
|
Interdisciplinary Communication | 1 | 2012 | 950 | 0.070 |
Why?
|
Adult | 8 | 2021 | 214055 | 0.070 |
Why?
|
Radiotherapy | 1 | 2013 | 1533 | 0.070 |
Why?
|
Patient Education as Topic | 2 | 2012 | 2278 | 0.070 |
Why?
|
Disease Management | 1 | 2016 | 2459 | 0.060 |
Why?
|
Salvage Therapy | 1 | 2011 | 1275 | 0.060 |
Why?
|
Lymphatic Metastasis | 1 | 2013 | 2924 | 0.060 |
Why?
|
Patient Care Team | 2 | 2013 | 2531 | 0.060 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 5221 | 0.060 |
Why?
|
Insurance, Health | 1 | 2016 | 2494 | 0.060 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15540 | 0.060 |
Why?
|
Insurance Coverage | 1 | 2014 | 1901 | 0.060 |
Why?
|
Guideline Adherence | 1 | 2013 | 2266 | 0.060 |
Why?
|
Medicaid | 1 | 2016 | 2736 | 0.050 |
Why?
|
Patient Participation | 1 | 2012 | 1457 | 0.050 |
Why?
|
Protons | 3 | 2013 | 1127 | 0.050 |
Why?
|
Prospective Studies | 4 | 2021 | 53288 | 0.050 |
Why?
|
Developing Countries | 1 | 2014 | 2815 | 0.050 |
Why?
|
Seminal Vesicles | 2 | 2011 | 101 | 0.050 |
Why?
|
Follow-Up Studies | 4 | 2021 | 39050 | 0.050 |
Why?
|
Brain Neoplasms | 1 | 2022 | 8863 | 0.050 |
Why?
|
Patient Compliance | 1 | 2012 | 2684 | 0.050 |
Why?
|
Treatment Outcome | 5 | 2021 | 63114 | 0.050 |
Why?
|
Databases, Factual | 1 | 2016 | 7729 | 0.050 |
Why?
|
Internet | 1 | 2012 | 3064 | 0.050 |
Why?
|
Neoplasm Invasiveness | 3 | 2013 | 3616 | 0.040 |
Why?
|
Healthcare Disparities | 1 | 2014 | 3158 | 0.040 |
Why?
|
Organs at Risk | 1 | 2021 | 346 | 0.040 |
Why?
|
Young Adult | 2 | 2016 | 56430 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2022 | 13102 | 0.040 |
Why?
|
Prostate-Specific Antigen | 2 | 2021 | 2494 | 0.040 |
Why?
|
Prognosis | 2 | 2014 | 29063 | 0.030 |
Why?
|
Boston | 3 | 2014 | 9313 | 0.030 |
Why?
|
Delivery of Health Care | 1 | 2013 | 5319 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2012 | 9959 | 0.030 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2022 | 1660 | 0.030 |
Why?
|
Forefoot, Human | 1 | 2014 | 32 | 0.030 |
Why?
|
Time Factors | 5 | 2017 | 40075 | 0.030 |
Why?
|
Retrospective Studies | 6 | 2022 | 77449 | 0.030 |
Why?
|
Qualitative Research | 2 | 2012 | 2682 | 0.030 |
Why?
|
Kinetics | 1 | 2021 | 6473 | 0.030 |
Why?
|
Risk Factors | 6 | 2021 | 72290 | 0.030 |
Why?
|
Female | 6 | 2020 | 380194 | 0.030 |
Why?
|
Interinstitutional Relations | 1 | 2014 | 241 | 0.030 |
Why?
|
Capacity Building | 1 | 2014 | 248 | 0.030 |
Why?
|
Hydronephrosis | 1 | 2013 | 269 | 0.030 |
Why?
|
Botswana | 1 | 2014 | 1040 | 0.020 |
Why?
|
Lactoglobulins | 1 | 1990 | 22 | 0.020 |
Why?
|
Receptors, Prolactin | 1 | 1990 | 17 | 0.020 |
Why?
|
Marital Status | 1 | 2012 | 437 | 0.020 |
Why?
|
Penis | 1 | 2011 | 216 | 0.020 |
Why?
|
Altruism | 1 | 2012 | 204 | 0.020 |
Why?
|
Advisory Committees | 1 | 2014 | 775 | 0.020 |
Why?
|
Femur Head | 1 | 2011 | 301 | 0.020 |
Why?
|
Area Under Curve | 1 | 2013 | 1654 | 0.020 |
Why?
|
Logistic Models | 2 | 2014 | 13408 | 0.020 |
Why?
|
United States | 1 | 2016 | 69872 | 0.020 |
Why?
|
Prolactin | 1 | 1990 | 669 | 0.020 |
Why?
|
HIV Infections | 1 | 2014 | 16718 | 0.020 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2012 | 547 | 0.020 |
Why?
|
Risk Assessment | 3 | 2013 | 23338 | 0.020 |
Why?
|
Reimbursement, Incentive | 1 | 2012 | 540 | 0.020 |
Why?
|
Postoperative Care | 1 | 2013 | 1486 | 0.020 |
Why?
|
Intestinal Diseases | 1 | 2011 | 530 | 0.020 |
Why?
|
Treatment Failure | 1 | 2011 | 2618 | 0.020 |
Why?
|
Adolescent | 1 | 2014 | 85781 | 0.020 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2013 | 941 | 0.020 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2014 | 2232 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2011 | 2886 | 0.020 |
Why?
|
Neoplasms | 1 | 2014 | 21683 | 0.020 |
Why?
|
Patient Preference | 1 | 2012 | 890 | 0.020 |
Why?
|
Prostate | 1 | 2011 | 1774 | 0.010 |
Why?
|
Motivation | 1 | 2012 | 1971 | 0.010 |
Why?
|
Transfection | 1 | 1990 | 5892 | 0.010 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2014 | 2020 | 0.010 |
Why?
|
Patient Satisfaction | 1 | 2013 | 3396 | 0.010 |
Why?
|
Neoadjuvant Therapy | 1 | 2011 | 2728 | 0.010 |
Why?
|
Radiography | 1 | 2011 | 7023 | 0.010 |
Why?
|
Biopsy | 1 | 2012 | 6756 | 0.010 |
Why?
|
Patient Selection | 1 | 2012 | 4215 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 1990 | 5867 | 0.010 |
Why?
|
Disease Progression | 1 | 2015 | 13284 | 0.010 |
Why?
|
Comorbidity | 1 | 2012 | 10388 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2012 | 15076 | 0.010 |
Why?
|
DNA | 1 | 1990 | 7301 | 0.010 |
Why?
|
Brain | 1 | 2022 | 26385 | 0.010 |
Why?
|
Physicians | 1 | 2014 | 4567 | 0.010 |
Why?
|
Age Factors | 1 | 2012 | 18370 | 0.010 |
Why?
|
Cohort Studies | 1 | 2015 | 40561 | 0.010 |
Why?
|
Cricetinae | 1 | 1990 | 2472 | 0.000 |
Why?
|
Gene Expression | 1 | 1990 | 7799 | 0.000 |
Why?
|
Cell Line | 1 | 1990 | 15997 | 0.000 |
Why?
|
Animals | 1 | 1990 | 168757 | 0.000 |
Why?
|
Concepts
(145)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(34)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_